These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27931517)

  • 1. Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells.
    Oh S; Kim H; Nam K; Shin I
    BMB Rep; 2017 Mar; 50(3):132-137. PubMed ID: 27931517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma.
    Zhou Z; Li Y; Chen S; Xie Z; Du Y; Liu Y; Shi Y; Lin X; Zeng X; Zhao H; Chen G
    Cell Commun Signal; 2024 Jun; 22(1):303. PubMed ID: 38831321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer.
    Troschel FM; Minte A; Ismail YM; Kamal A; Abdullah MS; Ahmed SH; Deffner M; Kemper B; Kiesel L; Eich HT; Ibrahim SA; Götte M; Greve B
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
    Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
    Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.
    Wu Q; Ba-Alawi W; Deblois G; Cruickshank J; Duan S; Lima-Fernandes E; Haight J; Tonekaboni SAM; Fortier AM; Kuasne H; McKee TD; Mahmoud H; Kushida M; Cameron S; Dogan-Artun N; Chen W; Nie Y; Zhang LX; Vellanki RN; Zhou S; Prinos P; Wouters BG; Dirks PB; Done SJ; Park M; Cescon DW; Haibe-Kains B; Lupien M; Arrowsmith CH
    Nat Commun; 2020 Aug; 11(1):4205. PubMed ID: 32826891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.
    Wang YD; Li SJ; Liao JX
    Technol Cancer Res Treat; 2013 Dec; 12(6):525-35. PubMed ID: 23617290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.
    Shen M; Jiang YZ; Wei Y; Ell B; Sheng X; Esposito M; Kang J; Hang X; Zheng H; Rowicki M; Zhang L; Shih WJ; Celià-Terrassa T; Liu Y; Cristea I; Shao ZM; Kang Y
    Cancer Cell; 2019 Jan; 35(1):64-80.e7. PubMed ID: 30612941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of Glut1 induces chemoresistance via modulation of Akt/GSK-3β/β-catenin/survivin signaling pathway in breast cancer cells.
    Oh S; Kim H; Nam K; Shin I
    Arch Biochem Biophys; 2017 Dec; 636():110-122. PubMed ID: 28803837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A.
    Tang Y; Cao K; Wang Q; Chen J; Liu R; Wang S; Zhou J; Xie H
    Oncol Rep; 2016 May; 35(5):2907-15. PubMed ID: 26934938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.
    Chen B; Tang H; Liu X; Liu P; Yang L; Xie X; Ye F; Song C; Xie X; Wei W
    Cancer Lett; 2015 Jan; 356(2 Pt B):410-7. PubMed ID: 25304371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro effect of the diabetes-associated markers insulin, leptin and oxidative stress on cellular characteristics promoting breast cancer progression is GLUT1-dependent.
    Silva C; Andrade N; Guimarães JT; Patrício E; Martel F
    Eur J Pharmacol; 2021 May; 898():173980. PubMed ID: 33647254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1.
    Li Y; Liu Y; Zhu H; Chen X; Tian M; Wei Y; Gong Y; Jiang J
    FEBS Lett; 2020 Jan; 594(2):358-366. PubMed ID: 31494931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted blocking of EGFR and GLUT1 by compound H reveals a new strategy for treatment of triple-negative breast cancer and nasopharyngeal carcinoma.
    Wang C; Li Z; Zhai H; Shen X; Li F; Zhang Q; Li D; Hou H
    Eur J Pharm Sci; 2024 Jul; 198():106789. PubMed ID: 38710335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation.
    Zou M; Li Y; Xia S; Chu Q; Xiao X; Qiu H; Chen Y; Zheng Z; Liu F; Zhuang L; Yu S
    Cell Physiol Biochem; 2017; 44(2):778-791. PubMed ID: 29169152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
    Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
    Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of TRIM66 in MDA-MB-468 triple negative breast cancer cell line suppresses proliferation and promotes apoptosis through EGFR signaling.
    Zhang H; Zheng Y; Zhang Y
    Pol J Pathol; 2021; 72(2):160-166. PubMed ID: 34706523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.